Conclusion
Radiotherapy remains an important adjuvant following local excision even in patients who also receive adjuvant systemic therapy.
Similar content being viewed by others
References
Auquier, A., L. E. Rutqvist, H. Host et al.: Post-mastectomy megavoltage radiotherapy: the Oslo and Stockholm trials. Europ. J. Cancer 28 (1992), 433–437.
Porrest, A. P., H. J. Stewart, D. Everington et al.: Randomized controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet 348 (1996), 708–713.
Kemperman, H., J. Borger, A. Hart et al.: Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence. Europ. J. Cancer 31-A (1995), 690–698.
Levitt, S. J., D. M. Aeppli, M. E. Nierengarten: The importance of control in the conservative treatment of breast cancer. Acta Oncol. 34 (1995), 839–844.
National Cancer Institute: Reanalysis of the NSABP Protocol B06. Emmes Corporation. Cancer Net, National Cancer Institute, 11 April 1994.
Schnitt, S. J., J. Hayman, R. Gelman et al.: A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer 77 (1996), 1094–1100.
Whelan, T., R. Clark, R. Roberts et al. Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 30 (1994), 11–16.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levitt, S.H. Radiotherapy Is a Necessary Adjuvant in the Treatment of Early Breast Cancer. Strahlenther. Onkol. 173, 435–436 (1997). https://doi.org/10.1007/BF03038323
Issue Date:
DOI: https://doi.org/10.1007/BF03038323